STENO — StenoCare A/S Share Price
Last trade - 00:00- DKK92.52m
- DKK92.70m
- DKK3.76m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.58 | ||
| Price to Tang. Book | 3.58 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 24.62 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -59.6% | ||
| Return on Equity | -70.33% | ||
| Operating Margin | -424.36% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | DKKm | 4.94 | 0.2 | 1.89 | 4.49 | 3.76 | n/a | n/a | -1.94% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
STENOCARE A/S is a Denmark-based company, which is engaged in the production of medical cannabis products to patients. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The Company distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.
Directors
- Marianne Wier CHM (58)
- Thomas Skovlund Schnegelsberg CEO (56)
- Soeren Kjaer CFD (57)
- Peter Bugge Johansen CFO (59)
- Rolf Steno Petersen OTH (56)
- Soeren Melsing Frederiksen DRC (45)
- Jeppe Petersen IND (55)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- October 19th, 2017
- Public Since
- October 26th, 2018
- No. of Employees
- 9
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange - Copenhagen
- Shares in Issue
- 18,140,626
- Address
- Nyholmsvej 4, Randers NOe, RANDERS, 8930
- Web
- https://stenocare.dk/
- Phone
- Auditors
- PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELS
Upcoming Events for STENO
Similar to STENO
Alk-Abello A/S
OMX Nordic Exchange - Copenhagen
Bavarian Nordic A/S
OMX Nordic Exchange - Copenhagen
H Lundbeck A/S
OMX Nordic Exchange - Copenhagen
H Lundbeck A/S
OMX Nordic Exchange - Copenhagen
Novo Nordisk A/S
OMX Nordic Exchange - Copenhagen
FAQ
As of Today at 19:20 UTC, shares in StenoCare A/S are trading at DKK5.10. This share price information is delayed by 15 minutes.
Shares in StenoCare A/S last closed at DKK5.10 and the price had moved by -36.14% over the past 365 days. In terms of relative price strength the StenoCare A/S share price has underperformed the FTSE Global All Cap Index by -41.32% over the past year.
There is no consensus recommendation for this security.
StenoCare A/S does not currently pay a dividend.
StenoCare A/S does not currently pay a dividend.
StenoCare A/S does not currently pay a dividend.
To buy shares in StenoCare A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of DKK5.10, shares in StenoCare A/S had a market capitalisation of DKK92.52m.
Here are the trading details for StenoCare A/S:
- Country of listing: Denmark
- Exchange: CPH
- Ticker Symbol: STENO
Based on an overall assessment of its quality, value and momentum StenoCare A/S is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like StenoCare A/S. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +38.94%.
As of the last closing price of DKK5.10, shares in StenoCare A/S were trading +39.72% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The StenoCare A/S PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at DKK5.10.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
StenoCare A/S' management team is headed by:
- Marianne Wier - CHM
- Thomas Skovlund Schnegelsberg - CEO
- Soeren Kjaer - CFD
- Peter Bugge Johansen - CFO
- Rolf Steno Petersen - OTH
- Soeren Melsing Frederiksen - DRC
- Jeppe Petersen - IND